1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsEarly Career Catalyst Grants for Translational Neuro-Oncology Research is sponsored by Society for Neuro-Oncology (SNO) / Beat Brain Cancer. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Early Career Catalyst Grants for Translational Neuro-Oncology Research | The Society for Neuro-Oncology Early Career Catalyst Grants for Translational Neuro-Oncology Research Early Career Catalyst Grants for Translational Neuro-Oncology Research Application Deadline: August 24, 2026 Funded by Beat Brain Cancer , the Foundation of the Society for Neuro-Oncology, the Early Career Catalyst Grants for Translational Neuro-Oncology Research are designed to support promising early-career investigators within seven years of completing fellowship who are conducting innovative translational research in neuro-oncology.
These grants aim to accelerate the movement of scientific discoveries from the laboratory into clinical application by funding projects with clear potential to impact patient care, therapeutic development, or clinical trial advancement.
In line with Beat Brain Cancer’s commitment to improving outcomes throughout the lifespan, two $60,000 awards will be granted: One award supporting translational research focused on adult brain tumors One award supporting translational research focused on pediatric/AYA brain tumors The application deadline is August 24, 2026.
In addition to the monetary award, the recipient will be featured on a SNO podcast and receive “fast track” consideration for an oral presentation at the SNO Annual Meeting. Through this award, Beat Brain Cancer seeks to foster the next generation of translational leaders committed to improving outcomes for patients with brain tumors. View the Terms & Conditions For more information, please contact Shelley Hwang .
According to the current listing, eligibility includes: Promising early-career investigators within seven years of completing a fellowship who are conducting innovative translational research in neuro-oncology. Confirm the full requirements in the official notice before applying.
The current listing shows $60,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 24, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Early Career Catalyst Grants for Translational Neuro-Oncology Research is funded by Society for Neuro-Oncology (SNO) / Beat Brain Cancer. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleARPA-H's HEARING program (ARPA-H-SOL-26-154) — Hearing Enhancement through ARtificially Intelligent NeurotechnoloGy — held its Proposers' Day on June 8, 2026 and set Solution Summary deadlines for June 29 with Full Proposals due August 14. Single prime awardee, multiple Other Transaction Agreements, three integrated technical areas spanning intracortical recording and stimulation devices, wearable dynamic sound modulators, and AI-based auditory read/write algorithms. The first phase runs 18 months; the full effort runs 4.5 years through first-in-human clinical studies. For neurotech teams that have spent a decade in cochlear-implant or visual-prosthesis space, this is the moment the federal government bet on auditory cortex over the cochlea.
Read articleOn May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read article